- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Gastroentero-pancreatic neuroendocrine carcinomas
Total 4322 results
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Melanoma (Skin)United States
-
National Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
National Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
National Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedIntraocular Melanoma | Melanoma (Skin)United States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
National Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedNeuroendocrine Carcinoma | Carcinoma of Unknown Primary | Neuroendocrine Carcinoma of the SkinUnited States
-
National Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLung Cancer | Islet Cell Tumor | Gastrointestinal Carcinoid Tumor | Neoplastic SyndromeUnited States
-
Navidea BiopharmaceuticalsCompletedMelanoma | Breast CancerUnited States
-
Navidea BiopharmaceuticalsCompletedMelanoma | Breast CancerUnited States, Israel
-
Baylor Research InstituteCompletedMalignant Melanoma Stage IVUnited States
-
Bristol-Myers SquibbCompleted
-
Massachusetts General HospitalAmerican Society for Gastrointestinal EndoscopyWithdrawnPancreatic Cancer | Pancreatic Diseases | Pancreatic Cyst | Pancreatic Surgery | Pancreatic Duct Stenting | Distal Pancreatectomy | Pancreatic DuctsUnited States
-
Molecular Insight Pharmaceuticals, Inc.TerminatedPheochromocytoma | ParagangliomaUnited States
-
University of RochesterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Melanoma (Skin)United States
-
National Cancer Institute (NCI)TerminatedRecurrent Melanoma | Stage IV MelanomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV MelanomaUnited States
-
National Cancer Institute (NCI)TerminatedStage IV Melanoma | Stage III MelanomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV MelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedIntraocular Melanoma | Melanoma (Skin)United States
-
National Cancer Institute (NCI)TerminatedGastrinoma | Glucagonoma | Insulinoma | Metastatic Gastrointestinal Carcinoid Tumor | Pancreatic Polypeptide Tumor | Recurrent Gastrointestinal Carcinoid Tumor | Recurrent Islet Cell Carcinoma | Somatostatinoma | Regional Gastrointestinal Carcinoid Tumor | Pulmonary Carcinoid TumorUnited States
-
Krankenhaus NordwestTerminatedChemo-refractory MelanomaGermany
-
National Cancer Institute (NCI)CompletedGastrinoma | Glucagonoma | Insulinoma | Metastatic Gastrointestinal Carcinoid Tumor | Pancreatic Polypeptide Tumor | Recurrent Gastrointestinal Carcinoid Tumor | Recurrent Islet Cell Carcinoma | Somatostatinoma | WDHA SyndromeUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Neuroendocrine Carcinoma of the Skin | Stage III Neuroendocrine Carcinoma of the Skin | Stage IV Neuroendocrine Carcinoma of the Skin | Stage II Neuroendocrine Carcinoma of the Skin | Stage I Neuroendocrine Carcinoma of the SkinUnited States
-
Bristol-Myers SquibbNo longer available
-
National Cancer Institute (NCI)CompletedMelanoma | Malignant Melanoma | Melanoma, Experimental | Experimental MelanomasUnited States
-
University of Colorado, DenverNational Cancer Institute (NCI)Completed
-
University of Colorado, DenverNational Cancer Institute (NCI)Completed
-
Iceland Genomics CorporationNational Cancer Institute (NCI)CompletedMelanoma (Skin)Iceland
-
Hadassah Medical OrganizationUnknownMetastatic Disease | High Risk HLA-A2+ Melanoma
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI)CompletedMelanoma (Skin)Canada
-
Eanm Research LtdWithdrawnMedullary Thyroid CarcinomaGermany
-
Bristol-Myers SquibbNational Cancer Institute (NCI)Withdrawn
-
Mid-Atlantic Oncology ProgramCancer Biotherapy Research GroupCompletedLung Cancer | Gastrointestinal Carcinoid TumorUnited States
-
Hackensack Meridian HealthNational Cancer Institute (NCI)WithdrawnMelanoma (Skin)United States
-
Novartis PharmaceuticalsCompletedPancreatic Neoplasms | Neuroendocrine Tumor | Neuroendocrine Carcinoma | Islet Cell CarcinomaUnited States, Canada, Spain, Argentina, Germany, Belgium, Italy, France, Sweden, Australia, Netherlands
-
National Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV Melanoma | Stage IV Renal Cell Cancer | Recurrent Renal Cell Cancer | Stage III MelanomaUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Recurrent Melanoma | Stage IV Melanoma | Stage IV Renal Cell Cancer | Recurrent Renal Cell CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Childhood Medulloblastoma | Recurrent Childhood Ependymoma | Childhood Atypical Teratoid/Rhabdoid Tumor | Extra-adrenal Paraganglioma | Childhood Choroid Plexus Tumor | Childhood Craniopharyngioma | Childhood Ependymoblastoma | Childhood Grade I Meningioma | Childhood Grade II Meningioma | Childhood... and other conditionsUnited States, Canada
-
New England Retina AssociatesCompleted
-
Novartis PharmaceuticalsCompletedLymphoma | Breast Cancer | Lung Cancer | Brain and Central Nervous System Tumors | Melanoma (Skin) | Islet Cell Tumor | Gastrointestinal Carcinoid Tumor | Neoplastic SyndromeUnited States
-
Medical University of ViennaTerminated
-
Centre Hospitalier Universitaire VaudoisCompleted
-
Centre Hospitalier Universitaire VaudoisLudwig Institute for Cancer ResearchCompleted
-
University of Alabama at BirminghamNational Cancer Institute (NCI)Completed